Analystreport

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Credit Suisse Group AG from $102.00 to $100.00. They now have an "outperform

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com